Analysts expect Alterity Therapeutics Ltd to report revenue of 1.58 M for 2027, against a range of 1.47 M to 1.69 M. The most recent reported year, 2026, came in at 1.23 M, a 39.3% miss against the 2.03 M consensus.
| Metric | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 1,720.00 | 10,610.00 | 182,310.00 | 292,100.00 | 1.23 M | - | - | ||
| High Estimate | 3.00 M | 3.42 M | 2.94 M | 6.30 M | 2.13 M | 1.69 M | 3.90 M | ||
| Low Estimate | 2.77 M | 2.84 M | 2.46 M | 5.34 M | 1.93 M | 1.47 M | 3.33 M | ||
| Consensus Estimate | 2.89 M | 3.13 M | 2.70 M | 5.82 M | 2.03 M | 1.58 M | 3.62 M |
Analysts expect Alterity Therapeutics Ltd to report earnings per share of -0.22 for 2027, against a range of -0.23 to -0.21. The most recent reported year, 2026, came in at -0.07, a 81.6% beat against the -0.38 consensus.
| Metric | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -2.18 | -2.21 | -2.12 | -0.75 | -0.07 | - | - | ||
| High Estimate | -3.10 | -1.25 | -1.75 | -0.93 | -0.34 | -0.21 | -0.32 | ||
| Low Estimate | -3.72 | -1.43 | -2.05 | -1.09 | -0.42 | -0.23 | -0.34 | ||
| Consensus Estimate | -3.41 | -1.34 | -1.90 | -1.01 | -0.38 | -0.22 | -0.33 |
Pull Wall Street consensus for Alterity Therapeutics Ltd (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=ATHE&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "ATHE", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=ATHE&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();